Trending...
- How to Choose the Best Bamboo Cheese Board for Your Kitchen
- PulteGroup announces new community in North Jacksonville, Wingate Landing
- DCOTA Hosts Design Professionals & Industry Insiders at the SUMMER REFRESH MARKET
SARASOTA, Fla.--(BUSINESS WIRE)--Akron Bio, a leading developer and manufacturer of critical building blocks used by biopharma to produce advanced therapies for the prevention and treatment of cardiovascular diseases and cancers, today launched a new, state-of-the-art cGMP (Current Good Manufacturing Practice) plasmid DNA manufacturing facility in Sarasota, Florida.
Akron Bio's Sarasota facility will address critical demands in the rapidly growing gene therapy and vaccine markets by providing plasmid DNA, an important ancillary material used in the manufacture of advanced therapies. The new site will support an increasing clinical development pipeline by relieving and securing industry supply. Akron Bio continues to set industry standards, in collaboration with global standard organizations and therapeutic providers, to ensure consistency, efficacy and safety of these advanced therapies.
"At Akron Bio, we are highly motivated by the lasting impact that cell and gene therapies, and vaccine treatments, have on patients' lives," said Robert Wedinger, Chief Executive Officer of Akron Bio. "This new facility will allow us to continue to drive the industry forward, while ensuring the highest quality and safety standards."
More on The Floridant
Akron Bio selected Manatee County for its new facility location because of the rapidly emerging biomedical hub in the region as well as the support of local and state government. As part of its expansion, Akron Bio will double its Sarasota workforce to more than 100 by the end of 2022, with plans to expand in the future to meet the growing customer demand.
"We are excited that Akron Bio has continued to demonstrate its commitment to Florida by developing a biomanufacturing workforce in Sarasota, further establishing Florida's position at the forefront of the life sciences industry," stated Nancy Bryan, President and Chief Executive Officer, BioFlorida.
Founded in 2006 and headquartered in Boca Raton, Florida, Akron Bio's mission is to drive advanced therapy development through the manufacturing and commercialization of high-quality, well-documented ancillary materials. The new Sarasota facility will expand the innovation and biomanufacturing footprint in the area – resulting in the acceleration of safer and more consistent therapeutic breakthroughs.
More on The Floridant
For more information, please visit https://akronbiotech.com/pdna-manufacturing/all.
About Akron Bio
Akron Bio is a leading materials manufacturer and services provider to the regenerative medicine industry. Akron's Boca facility is ISO 13485-certified operating in line with cGMP guidelines and international standards, Akron Bio leverages more than 100,000 square feet of development and manufacturing capacity to provide advanced therapy developers the scale, compliance and regulatory support necessary to drive novel treatments from discovery to commercialization. For more information, please visit www.akronbiotech.com.
Contacts
Akron Bio
Dolores Baksh
media@akronbiotech.com
Akron Bio's Sarasota facility will address critical demands in the rapidly growing gene therapy and vaccine markets by providing plasmid DNA, an important ancillary material used in the manufacture of advanced therapies. The new site will support an increasing clinical development pipeline by relieving and securing industry supply. Akron Bio continues to set industry standards, in collaboration with global standard organizations and therapeutic providers, to ensure consistency, efficacy and safety of these advanced therapies.
"At Akron Bio, we are highly motivated by the lasting impact that cell and gene therapies, and vaccine treatments, have on patients' lives," said Robert Wedinger, Chief Executive Officer of Akron Bio. "This new facility will allow us to continue to drive the industry forward, while ensuring the highest quality and safety standards."
More on The Floridant
- The Pelican Café to Celebrate Publication of 'The Contemporary Singer's Blueprint' by Jill Switzer o
- Fusion Growth Partners Named one of America's Fastest Growing Private Companies in the 2022 Inc. 5000
- Chemours Begins Commissioning at Its Newest Sand Mine in Clay County, Florida
- Woodfield Fine Art Gallery Hosts Open Art Forum at the Poynter
- Contracting Resources Group, Inc. Named on Inc. 5000 List of Fastest-Growing Private Companies for Fifth Year
Akron Bio selected Manatee County for its new facility location because of the rapidly emerging biomedical hub in the region as well as the support of local and state government. As part of its expansion, Akron Bio will double its Sarasota workforce to more than 100 by the end of 2022, with plans to expand in the future to meet the growing customer demand.
"We are excited that Akron Bio has continued to demonstrate its commitment to Florida by developing a biomanufacturing workforce in Sarasota, further establishing Florida's position at the forefront of the life sciences industry," stated Nancy Bryan, President and Chief Executive Officer, BioFlorida.
Founded in 2006 and headquartered in Boca Raton, Florida, Akron Bio's mission is to drive advanced therapy development through the manufacturing and commercialization of high-quality, well-documented ancillary materials. The new Sarasota facility will expand the innovation and biomanufacturing footprint in the area – resulting in the acceleration of safer and more consistent therapeutic breakthroughs.
More on The Floridant
- Former Marine Sargent Michael J. Rotch Launches Life Coaching Program, Helping People Find Their Voice
- Climate Justice Advocate, Felicia Davis, Statement on the Inflation Reduction Act
- DLP Capital Named to Inc. 5000 "Fastest Growing Private Companies" for 10th Consecutive Year
- Update on I-5 Project, Black Prime Contractor Raimore Construction
- Florida: Governor Ron DeSantis Announces Three New Initiatives to Elevate Teachers and Students' Learning
For more information, please visit https://akronbiotech.com/pdna-manufacturing/all.
About Akron Bio
Akron Bio is a leading materials manufacturer and services provider to the regenerative medicine industry. Akron's Boca facility is ISO 13485-certified operating in line with cGMP guidelines and international standards, Akron Bio leverages more than 100,000 square feet of development and manufacturing capacity to provide advanced therapy developers the scale, compliance and regulatory support necessary to drive novel treatments from discovery to commercialization. For more information, please visit www.akronbiotech.com.
Contacts
Akron Bio
Dolores Baksh
media@akronbiotech.com
Filed Under: Business
0 Comments
Latest on The Floridant
- Summit Report Released: Keeping Schools Open in 2022 and Beyond
- Jacksonville: ACPS Announces Appointment-Based Approach for Animal Intake
- Cross Country Healthcare to Attend The 15th Annual Barrington Research Virtual Fall Conference
- More Money for you to help reduce Carbon Pollution, Inflation Reduction Act - ECOFuelMax
- Berkshire Hathaway HomeServices FNR Donates Backpacks and School Supplies to Local Students
- Bold New Book, If Only We Knew, Offers A Framework To Understand And Solve Today's Social Issues
- Living Waters Inc to Host the "2022 Mental Health Summit"
- Greater Fort Myers Chamber celebrates community excellence at inaugural Chamber Awards
- Moss Foundation 17th Annual Back to School Drive Raises $117K
- Seneca at Oak Creek by Sage Communities now accepting reservations
- Wood Underwear® FW22 Introduces New Styles in Lounge
- New from Down & Out Books: SNAKE SLAYER by Rob Pierce
- Family Initiative hires Rachel Fecteau as community engagement specialist
- Diaz Trade Law Welcomes New Managing Attorney Mrs. Coraly Schreiber
- Diversified Maintenance Announces Acquisition of Pennsylvania Based Millers Cleaning Services
- Loxperts Inc. launches the first-ever on-demand freelancer marketplace dedicated to localization experts
- Terran Orbital Wins Mission of the Year for CAPSTONE Spacecraft
- Coral Springs Center for the Arts to Present JOHNNY MATHIS: The Voice of Romance Tour on March 23
- Now available on Amazon Kindle: New book "The Final Days of Doggerland" by Mike Meier
- Coral Springs Center for the Arts to Present NEWSBOYS: Stand Together Tour on October 13